Synergy Innovation Co., Ltd. (KOSDAQ:048870)
South Korea · Delayed Price · Currency is KRW 1,784.00
-38.00 (-2.09%)
At close: May 20, 2026
Synergy Innovation Market Cap
Synergy Innovation has a market cap or net worth of 157.18 billion as of May 21, 2026. Its market cap has decreased by -36.98% in one year.
Market Cap
157.18B
Enterprise Value
171.10B
Revenue
113.05B
Ranking
n/a
PE Ratio
51.27
Stock Price
1,784.00
Market Cap Chart
Since August 13, 2004, Synergy Innovation's market cap has decreased from 179.32B to 157.18B, a decrease of -12.35%. That is a compound annual growth rate of -0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 157.18B | -23.92% |
| Dec 30, 2025 | 206.61B | -3.74% |
| Dec 30, 2024 | 214.63B | -4.95% |
| Dec 28, 2023 | 225.79B | -2.15% |
| Dec 29, 2022 | 230.76B | -32.68% |
| Dec 30, 2021 | 342.79B | 27.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG MedTech | 166.66B |
| Amosense | 166.62B |
| GC Genome | 166.03B |
| Avatec | 165.38B |
| KG Financial | 164.57B |
| CORESTEMCHEMON | 164.13B |
| Daihan Pharmaceutical | 163.76B |
| Dongbang Medical | 163.70B |